MPEYX
Price
$9.98
Change
+$0.01 (+0.10%)
Updated
Dec 20 closing price
RNWFX
Price
$77.72
Change
+$0.12 (+0.15%)
Updated
Dec 20 closing price
Ad is loading...

MPEYX vs RNWFX

Header iconMPEYX vs RNWFX Comparison
Open Charts MPEYX vs RNWFXBanner chart's image
MassMutual Strat Emerg Mkts Svc
Price$9.98
Change+$0.01 (+0.10%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$77.72
Change+$0.12 (+0.15%)
VolumeN/A
CapitalizationN/A
MPEYX vs RNWFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MPEYX vs. RNWFX commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MPEYX is a StrongBuy and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 62.2B vs. MPEYX (95.7M). RNWFX pays higher dividends than MPEYX: RNWFX (1.51) vs MPEYX (0.00). MPEYX was incepted earlier than RNWFX: MPEYX (16 years) vs RNWFX (23 years). MPEYX is a more actively managed with annual turnover of: 38.00 vs. RNWFX (32.00). MPEYX has a lower initial minimum investment than RNWFX: MPEYX (0) vs RNWFX (250). RNWFX annual gain was more profitable for investors over the last year : 5.86 vs. MPEYX (0.87). RNWFX return over 5 years is better than : 14.39 vs. MPEYX (-24.63).
MPEYXRNWFXMPEYX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence16 years23 years-
Gain YTD-0.4344.549-10%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets95.7M62.2B0%
Annual Yield % from dividends0.001.51-
Returns for 1 year0.875.8615%
Returns for 3 years-17.21-5.10337%
Returns for 5 years-24.6314.39-171%
Returns for 10 years-6.6842.67-16%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VTRS12.520.39
+3.22%
Viatris
TEO11.890.14
+1.19%
Telecom Argentina SA
DX12.570.14
+1.13%
Dynex Capital
INTT7.680.04
+0.52%
inTEST Corp
VIRX0.21N/A
-1.87%
Viracta Therapeutics